Share Price and Basic Stock Data
Last Updated: December 9, 2025, 9:31 pm
| PEG Ratio | 5.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
S H Kelkar & Company Ltd (SHK) operates in the chemicals sector, primarily focusing on specialty chemicals. The company’s revenue trajectory has shown a notable upward trend, with sales increasing from ₹1,564 Cr in FY 2022 to ₹1,687 Cr in FY 2023, and further projected to reach ₹2,123 Cr in FY 2025. In the latest quarter ending September 2023, sales were reported at ₹455 Cr, reflecting a steady recovery post-pandemic. This consistent growth suggests that SHK has successfully navigated market challenges, capitalizing on its niche in the specialty chemicals domain. Moreover, the operating profit margin (OPM) has fluctuated but stood at a healthy 17% in FY 2024, indicating effective cost management and operational efficiency. As SHK continues to enhance its product portfolio and expand its market reach, its revenue growth appears strong, reinforcing its position in the industry.
Profitability and Efficiency Metrics
Profitability metrics for SHK display a mixed yet encouraging picture. The net profit for FY 2023 was reported at ₹63 Cr, with a net profit margin of 3.50% in the last fiscal year. Notably, the interest coverage ratio (ICR) stood at 6.49x, suggesting that the company comfortably meets its interest obligations, a positive sign of financial health. However, the return on equity (ROE) remained modest at 7.70%, which may be a concern for investors seeking high returns. The company’s cash conversion cycle (CCC) of 187 days indicates a reasonable time frame for converting inventory into cash, although it could be streamlined further to enhance liquidity. Overall, while SHK demonstrates solid profitability and efficiency metrics, there are areas to improve, especially in enhancing shareholder returns.
Balance Sheet Strength and Financial Ratios
Examining SHK’s balance sheet reveals a company that is managing its financial obligations with a degree of caution. The total borrowings stood at ₹889 Cr against reserves of ₹1,191 Cr, suggesting a healthy reserve cushion relative to debt levels. The debt-to-equity ratio of 0.58 indicates a balanced approach to leveraging, as the company is not overly reliant on debt for financing its operations. Furthermore, the price-to-book value (P/BV) ratio of 1.93x suggests that the stock is trading at a reasonable premium to its book value, reflecting investor confidence in its future prospects. However, the working capital days have decreased to 62 days, which implies that the company is managing its short-term liabilities efficiently. This balance sheet strength positions SHK well, but investors should remain cautious about the level of debt relative to its earnings potential.
Shareholding Pattern and Investor Confidence
The shareholding pattern of SHK reveals a diverse ownership structure, with promoters holding 54.87% of the shares. This level of promoter holding indicates a strong commitment to the company’s success, which can inspire confidence among retail investors. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold 7.36% and 5.69% respectively, reflecting a cautious but positive sentiment from institutional players. The public shareholding has seen a slight decline to 32.08%, which could signify either a consolidation of shares by larger investors or reduced interest from retail investors. The fluctuation in share ownership dynamics may impact investor confidence, especially if the public’s stake continues to dwindle. Overall, the strong promoter stake coupled with institutional interest presents a reassuring picture for potential investors.
Outlook, Risks, and Final Insight
Looking ahead, SHK’s outlook appears optimistic but not without risks. The company is well-positioned to leverage the growing demand for specialty chemicals, but it must navigate challenges such as raw material price volatility and regulatory changes in the chemicals sector. Additionally, the fluctuations in net profit and the relatively low ROE could deter some investors seeking robust returns. The ongoing geopolitical tensions and global economic uncertainties may also pose risks to SHK’s international operations. For investors, the key will be to weigh these potential risks against the company’s growth prospects and financial stability. As SHK continues to adapt to market conditions and enhance its operational efficiencies, it may present a compelling case for long-term investment. However, investors should proceed with caution, considering both the inherent risks in the chemicals sector and SHK’s current financial metrics.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of S H Kelkar & Company Ltd (SHK)
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 256 Cr. | 262 | 541/250 | 158 | 0.38 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 26.6 Cr. | 63.4 | 97.0/56.0 | 14.5 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,028 Cr. | 76.1 | 104/64.9 | 12.9 | 121 | 1.05 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 945 Cr. | 106 | 130/63.6 | 9.44 | 109 | 1.14 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 85,865 Cr. | 2,895 | 3,325/2,197 | 53.1 | 447 | 0.25 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 13,911.67 Cr | 1,132.53 | 32.40 | 204.33 | 0.42% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 415 | 414 | 385 | 472 | 423 | 455 | 472 | 513 | 470 | 542 | 543 | 567 | 581 |
| Expenses | 360 | 363 | 341 | 405 | 355 | 384 | 396 | 424 | 392 | 462 | 480 | 494 | 508 |
| Operating Profit | 55 | 52 | 43 | 67 | 68 | 72 | 76 | 90 | 78 | 80 | 64 | 73 | 73 |
| OPM % | 13% | 12% | 11% | 14% | 16% | 16% | 16% | 17% | 17% | 15% | 12% | 13% | 13% |
| Other Income | 1 | 9 | 2 | -20 | 2 | 2 | 2 | -0 | -120 | 21 | 1 | 61 | 3 |
| Interest | 5 | 5 | 6 | 7 | 10 | 10 | 10 | 10 | 10 | 13 | 14 | 13 | 13 |
| Depreciation | 20 | 20 | 20 | 21 | 21 | 22 | 22 | 22 | 22 | 24 | 23 | 25 | 26 |
| Profit before tax | 31 | 35 | 19 | 19 | 39 | 41 | 46 | 57 | -74 | 64 | 27 | 97 | 37 |
| Tax % | 26% | 28% | 29% | 94% | 28% | 27% | 30% | 42% | 17% | 38% | 36% | -6% | 30% |
| Net Profit | 23 | 25 | 13 | 1 | 28 | 30 | 32 | 33 | -87 | 40 | 18 | 103 | 26 |
| EPS in Rs | 1.56 | 1.75 | 0.94 | 0.17 | 1.96 | 2.12 | 2.33 | 2.45 | -6.25 | 2.87 | 1.27 | 7.41 | 1.85 |
Last Updated: August 20, 2025, 4:20 am
Below is a detailed analysis of the quarterly data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 581.00 Cr.. The value appears strong and on an upward trend. It has increased from 567.00 Cr. (Mar 2025) to 581.00 Cr., marking an increase of 14.00 Cr..
- For Expenses, as of Jun 2025, the value is 508.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 494.00 Cr. (Mar 2025) to 508.00 Cr., marking an increase of 14.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 73.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 73.00 Cr..
- For OPM %, as of Jun 2025, the value is 13.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 58.00 Cr..
- For Interest, as of Jun 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Depreciation, as of Jun 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 97.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 60.00 Cr..
- For Tax %, as of Jun 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from -6.00% (Mar 2025) to 30.00%, marking an increase of 36.00%.
- For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 103.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 77.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.85. The value appears to be declining and may need further review. It has decreased from 7.41 (Mar 2025) to 1.85, marking a decrease of 5.56.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:10 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 761 | 834 | 925 | 981 | 1,021 | 1,048 | 1,114 | 1,322 | 1,564 | 1,687 | 1,841 | 2,123 | 2,234 |
| Expenses | 628 | 716 | 774 | 814 | 862 | 908 | 955 | 1,083 | 1,350 | 1,469 | 1,537 | 1,828 | 1,944 |
| Operating Profit | 132 | 119 | 151 | 167 | 159 | 141 | 160 | 239 | 215 | 217 | 304 | 296 | 290 |
| OPM % | 17% | 14% | 16% | 17% | 16% | 13% | 14% | 18% | 14% | 13% | 17% | 14% | 13% |
| Other Income | 12 | 25 | 10 | 12 | 13 | 21 | -28 | 36 | 6 | -8 | 5 | -38 | 86 |
| Interest | 18 | 19 | 22 | 6 | 5 | 16 | 26 | 20 | 16 | 24 | 40 | 49 | 53 |
| Depreciation | 19 | 29 | 30 | 19 | 24 | 31 | 52 | 62 | 72 | 80 | 86 | 95 | 99 |
| Profit before tax | 109 | 94 | 110 | 153 | 143 | 115 | 54 | 194 | 132 | 104 | 183 | 114 | 225 |
| Tax % | 27% | 26% | 34% | 31% | 35% | 24% | 34% | 26% | -13% | 40% | 32% | 36% | |
| Net Profit | 79 | 70 | 73 | 105 | 94 | 88 | 36 | 144 | 149 | 63 | 124 | 73 | 185 |
| EPS in Rs | 5,980.35 | 5.32 | 5.05 | 7.25 | 6.49 | 6.12 | 2.53 | 10.24 | 10.73 | 4.42 | 8.84 | 5.29 | 13.40 |
| Dividend Payout % | 19% | 28% | 30% | 24% | 27% | 0% | 38% | 17% | 7% | 45% | 8% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.39% | 4.29% | 43.84% | -10.48% | -6.38% | -59.09% | 300.00% | 3.47% | -57.72% | 96.83% | -41.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 15.68% | 39.55% | -54.31% | 4.09% | -52.71% | 359.09% | -296.53% | -61.19% | 154.54% | -137.95% |
S H Kelkar & Company Ltd (SHK) has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 11% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 11% |
| 3 Years: | -15% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 21% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:15 pm
Balance Sheet
Last Updated: December 4, 2025, 1:54 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 | 138 |
| Reserves | 467 | 368 | 571 | 667 | 712 | 719 | 683 | 810 | 875 | 926 | 1,074 | 1,134 | 1,191 |
| Borrowings | 212 | 252 | 85 | 74 | 172 | 342 | 365 | 518 | 698 | 620 | 666 | 832 | 889 |
| Other Liabilities | 169 | 187 | 201 | 187 | 246 | 222 | 277 | 405 | 568 | 518 | 502 | 556 | 587 |
| Total Liabilities | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,805 |
| Fixed Assets | 251 | 274 | 227 | 296 | 352 | 462 | 472 | 741 | 959 | 914 | 933 | 953 | 1,052 |
| CWIP | 50 | 10 | 18 | 7 | 60 | 38 | 18 | 28 | 9 | 26 | 13 | 46 | 59 |
| Investments | 0 | 0 | 35 | 50 | 96 | 97 | 97 | 1 | 1 | 23 | 10 | 11 | 13 |
| Other Assets | 559 | 655 | 722 | 720 | 767 | 830 | 879 | 1,103 | 1,309 | 1,239 | 1,425 | 1,650 | 1,681 |
| Total Assets | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,805 |
Below is a detailed analysis of the balance sheet data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 138.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 138.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,191.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,134.00 Cr. (Mar 2025) to 1,191.00 Cr., marking an increase of 57.00 Cr..
- For Borrowings, as of Sep 2025, the value is 889.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 832.00 Cr. (Mar 2025) to 889.00 Cr., marking an increase of 57.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 587.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 556.00 Cr. (Mar 2025) to 587.00 Cr., marking an increase of 31.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,805.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,660.00 Cr. (Mar 2025) to 2,805.00 Cr., marking an increase of 145.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,052.00 Cr.. The value appears strong and on an upward trend. It has increased from 953.00 Cr. (Mar 2025) to 1,052.00 Cr., marking an increase of 99.00 Cr..
- For CWIP, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,681.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,650.00 Cr. (Mar 2025) to 1,681.00 Cr., marking an increase of 31.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,805.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,660.00 Cr. (Mar 2025) to 2,805.00 Cr., marking an increase of 145.00 Cr..
Notably, the Reserves (1,191.00 Cr.) exceed the Borrowings (889.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -80.00 | -133.00 | 66.00 | 93.00 | -13.00 | -201.00 | -205.00 | -279.00 | -483.00 | -403.00 | -362.00 | -536.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 85 | 90 | 81 | 99 | 99 | 104 | 103 | 108 | 95 | 97 | 87 |
| Inventory Days | 255 | 252 | 239 | 247 | 233 | 239 | 201 | 216 | 225 | 228 | 243 | 227 |
| Days Payable | 80 | 76 | 116 | 78 | 104 | 86 | 103 | 125 | 143 | 138 | 132 | 126 |
| Cash Conversion Cycle | 261 | 261 | 213 | 250 | 228 | 252 | 202 | 195 | 190 | 185 | 209 | 187 |
| Working Capital Days | 157 | 70 | 135 | 128 | 110 | 86 | 55 | 91 | 90 | 88 | 63 | 62 |
| ROCE % | 18% | 14% | 17% | 19% | 17% | 12% | 10% | 15% | 10% | 8% | 12% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Bandhan Small Cap Fund | 3,942,304 | 0.5 | 87.18 | N/A | N/A | N/A |
| LIC MF Small Cap Fund | 319,836 | 1.09 | 7.07 | N/A | N/A | N/A |
| LIC MF Balanced Advantage Fund | 303,558 | 0.88 | 6.71 | N/A | N/A | N/A |
| LIC MF Focused Fund | 301,129 | 3.79 | 6.66 | N/A | N/A | N/A |
| LIC MF Dividend Yield Fund | 294,810 | 0.93 | 6.52 | N/A | N/A | N/A |
| Tata Childrens Fund | 150,000 | 0.91 | 3.32 | N/A | N/A | N/A |
| LIC MF Value Fund | 125,240 | 1.31 | 2.77 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Diluted EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Cash EPS (Rs.) | 12.22 | 15.38 | 10.37 | 15.98 | 14.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Revenue From Operations / Share (Rs.) | 153.40 | 139.43 | 121.84 | 113.00 | 93.54 |
| PBDIT / Share (Rs.) | 23.18 | 22.60 | 16.55 | 16.77 | 18.35 |
| PBIT / Share (Rs.) | 16.34 | 16.15 | 10.74 | 11.59 | 14.00 |
| PBT / Share (Rs.) | 8.39 | 13.17 | 7.55 | 9.55 | 13.68 |
| Net Profit / Share (Rs.) | 5.37 | 8.93 | 4.56 | 10.79 | 10.17 |
| NP After MI And SOA / Share (Rs.) | 5.29 | 8.84 | 4.42 | 10.73 | 10.24 |
| PBDIT Margin (%) | 15.11 | 16.21 | 13.58 | 14.84 | 19.61 |
| PBIT Margin (%) | 10.65 | 11.58 | 8.81 | 10.25 | 14.96 |
| PBT Margin (%) | 5.47 | 9.44 | 6.19 | 8.45 | 14.62 |
| Net Profit Margin (%) | 3.50 | 6.40 | 3.74 | 9.55 | 10.87 |
| NP After MI And SOA Margin (%) | 3.44 | 6.34 | 3.62 | 9.49 | 10.94 |
| Return on Networth / Equity (%) | 5.75 | 10.09 | 5.74 | 14.66 | 15.20 |
| Return on Capital Employeed (%) | 14.55 | 15.22 | 9.82 | 10.20 | 14.93 |
| Return On Assets (%) | 2.72 | 5.09 | 2.75 | 6.46 | 7.62 |
| Long Term Debt / Equity (X) | 0.13 | 0.14 | 0.29 | 0.35 | 0.34 |
| Total Debt / Equity (X) | 0.58 | 0.50 | 0.53 | 0.62 | 0.51 |
| Asset Turnover Ratio (%) | 0.83 | 0.83 | 0.74 | 0.55 | 0.60 |
| Current Ratio (X) | 1.39 | 1.46 | 1.70 | 1.70 | 1.82 |
| Quick Ratio (X) | 0.75 | 0.75 | 0.85 | 0.93 | 1.07 |
| Inventory Turnover Ratio (X) | 3.09 | 3.06 | 1.72 | 1.58 | 1.82 |
| Dividend Payout Ratio (NP) (%) | 14.17 | 22.61 | 16.96 | 7.13 | 9.76 |
| Dividend Payout Ratio (CP) (%) | 6.18 | 13.07 | 7.32 | 4.81 | 6.85 |
| Earning Retention Ratio (%) | 85.83 | 77.39 | 83.04 | 92.87 | 90.24 |
| Cash Earning Retention Ratio (%) | 93.82 | 86.93 | 92.68 | 95.19 | 93.15 |
| Interest Coverage Ratio (X) | 6.49 | 7.58 | 9.59 | 14.35 | 15.19 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 3.99 | 4.49 | 10.97 | 8.69 |
| Enterprise Value (Cr.) | 3118.96 | 3356.30 | 1912.25 | 2576.78 | 1935.94 |
| EV / Net Operating Revenue (X) | 1.47 | 1.74 | 1.13 | 1.65 | 1.46 |
| EV / EBITDA (X) | 9.72 | 10.73 | 8.35 | 11.10 | 7.46 |
| MarketCap / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| Retention Ratios (%) | 85.82 | 77.38 | 83.03 | 92.86 | 90.23 |
| Price / BV (X) | 1.93 | 2.34 | 1.29 | 1.96 | 1.66 |
| Price / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| EarningsYield | 0.02 | 0.04 | 0.04 | 0.07 | 0.09 |
After reviewing the key financial ratios for S H Kelkar & Company Ltd (SHK), here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 15.38 (Mar 24) to 12.22, marking a decrease of 3.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 153.40. It has increased from 139.43 (Mar 24) to 153.40, marking an increase of 13.97.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.18. This value is within the healthy range. It has increased from 22.60 (Mar 24) to 23.18, marking an increase of 0.58.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.34. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 16.34, marking an increase of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.39. This value is within the healthy range. It has decreased from 13.17 (Mar 24) to 8.39, marking a decrease of 4.78.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.37, marking a decrease of 3.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.29. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 5.29, marking a decrease of 3.55.
- For PBDIT Margin (%), as of Mar 25, the value is 15.11. This value is within the healthy range. It has decreased from 16.21 (Mar 24) to 15.11, marking a decrease of 1.10.
- For PBIT Margin (%), as of Mar 25, the value is 10.65. This value is within the healthy range. It has decreased from 11.58 (Mar 24) to 10.65, marking a decrease of 0.93.
- For PBT Margin (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 10. It has decreased from 9.44 (Mar 24) to 5.47, marking a decrease of 3.97.
- For Net Profit Margin (%), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 6.40 (Mar 24) to 3.50, marking a decrease of 2.90.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 8. It has decreased from 6.34 (Mar 24) to 3.44, marking a decrease of 2.90.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.75. This value is below the healthy minimum of 15. It has decreased from 10.09 (Mar 24) to 5.75, marking a decrease of 4.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.22 (Mar 24) to 14.55, marking a decrease of 0.67.
- For Return On Assets (%), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 5. It has decreased from 5.09 (Mar 24) to 2.72, marking a decrease of 2.37.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 24) to 0.13, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.58, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. There is no change compared to the previous period (Mar 24) which recorded 0.83.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.75.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.09. This value is below the healthy minimum of 4. It has increased from 3.06 (Mar 24) to 3.09, marking an increase of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.17. This value is below the healthy minimum of 20. It has decreased from 22.61 (Mar 24) to 14.17, marking a decrease of 8.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 20. It has decreased from 13.07 (Mar 24) to 6.18, marking a decrease of 6.89.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.83. This value exceeds the healthy maximum of 70. It has increased from 77.39 (Mar 24) to 85.83, marking an increase of 8.44.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.82. This value exceeds the healthy maximum of 70. It has increased from 86.93 (Mar 24) to 93.82, marking an increase of 6.89.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.49. This value is within the healthy range. It has decreased from 7.58 (Mar 24) to 6.49, marking a decrease of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 3.75, marking a decrease of 0.24.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,118.96. It has decreased from 3,356.30 (Mar 24) to 3,118.96, marking a decrease of 237.34.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.47. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.47, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.72. This value is within the healthy range. It has decreased from 10.73 (Mar 24) to 9.72, marking a decrease of 1.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 25, the value is 85.82. This value exceeds the healthy maximum of 70. It has increased from 77.38 (Mar 24) to 85.82, marking an increase of 8.44.
- For Price / BV (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 1.93, marking a decrease of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in S H Kelkar & Company Ltd (SHK):
- Net Profit Margin: 3.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.55% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.75% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.1 (Industry average Stock P/E: 32.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.58
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Devkaran Mansion, Mumbai Maharashtra 400002 | investors@keva.co.in https://www.keva.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Vaze | Chairman & Non-Exe.Director |
| Mr. Kedar Vaze | WholeTime Director & Group CEO |
| Mrs. Prabha Vaze | Non Executive Director |
| Mr. Deepak Raj Bindra | Independent Director |
| Mr. Shrikant Oka | Independent Director |
| Mr. Vasant Gujarathi | Independent Director |
| Ms. Neela Bhattacherjee | Independent Director |
FAQ
What is the intrinsic value of S H Kelkar & Company Ltd (SHK)?
S H Kelkar & Company Ltd (SHK)'s intrinsic value (as of 09 December 2025) is 137.57 which is 17.13% lower the current market price of 166.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,301 Cr. market cap, FY2025-2026 high/low of 287/142, reserves of ₹1,191 Cr, and liabilities of 2,805 Cr.
What is the Market Cap of S H Kelkar & Company Ltd (SHK)?
The Market Cap of S H Kelkar & Company Ltd (SHK) is 2,301 Cr..
What is the current Stock Price of S H Kelkar & Company Ltd (SHK) as on 09 December 2025?
The current stock price of S H Kelkar & Company Ltd (SHK) as on 09 December 2025 is 166.
What is the High / Low of S H Kelkar & Company Ltd (SHK) stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of S H Kelkar & Company Ltd (SHK) stocks is 287/142.
What is the Stock P/E of S H Kelkar & Company Ltd (SHK)?
The Stock P/E of S H Kelkar & Company Ltd (SHK) is 23.1.
What is the Book Value of S H Kelkar & Company Ltd (SHK)?
The Book Value of S H Kelkar & Company Ltd (SHK) is 96.1.
What is the Dividend Yield of S H Kelkar & Company Ltd (SHK)?
The Dividend Yield of S H Kelkar & Company Ltd (SHK) is 0.60 %.
What is the ROCE of S H Kelkar & Company Ltd (SHK)?
The ROCE of S H Kelkar & Company Ltd (SHK) is 10.3 %.
What is the ROE of S H Kelkar & Company Ltd (SHK)?
The ROE of S H Kelkar & Company Ltd (SHK) is 7.70 %.
What is the Face Value of S H Kelkar & Company Ltd (SHK)?
The Face Value of S H Kelkar & Company Ltd (SHK) is 10.0.